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Faecal bacterial and short-
chain fatty acids signature in 
hypercholesterolemia
A. B. Granado-serrano1, M. Martín-Garí  1, V. sánchez2, M. Riart solans2, R. Berdún1, 
I. A. Ludwig3, L. Rubió4, e. Vilaprinyó5, M. portero-otín1 & J. C. e. serrano  1
Gut microbiota has been suggested to affect lipid metabolism. The objective of this study was to 
characterize the faecal microbiota signature and both short chain fatty acids (sCFAs) and bile acids (BA) 
profile of hypercholesterolemic subjects. Microbiota composition, SCFAs, BA and blood lipid profile 
from male volunteers with hypercholesterolemia (HC) and normocholesterolemia (NC) were determined 
by 16S rDNA sequencing, HPLC, GC and NMR, respectively. HC subjects were characterized by having 
lower relative abundance of Anaeroplasma (0.002% vs 0.219%, p-value = 0.026) and Haemophilus 
(0.041% vs 0.078%, p-value = 0.049), and higher of Odoribacter (0.51% vs 0.16%; p-value = 0.044). 
Correlation analysis revealed that Anaeroplasma and Haemophilus were associated to an unfavourable 
lipid profile: they correlated negatively to cholesterol and triglycerides related biomarkers and the ratio 
total to high density lipoprotein (HDL) cholesterol, and positively to HDL size. Odoribacter displayed 
an opposite behaviour. Faecal SCFAs profile revealed higher abundance of isobutyric (2.76% vs 0.82%, 
p-value = 0.049) and isovaleric acid (1.32% vs 0.06%, p-value = 0.016) in HC. Isobutyric acid correlated 
positively with Odoribacter and lipid parameters indicative of an unfavourable profile. BA profile did 
not show differences between groups. It was concluded that HC subjects showed a particular faecal 
bacterial signature and SCFAs profile associated with their lipid profile.
Cardiovascular diseases (CVDs) remain the biggest cause of deaths globally. More than 17.7 million people 
died of CVDs in 2015, representing 31% of all death worldwide1. Hypercholesterolemia is considered an impor-
tant modifiable risk factor of CVDs. Just in Spain, the prevalence of high total cholesterol (Total-C) levels (over 
200 mg/dL) is 50–60%2, which makes it one of the most prevalent risk factor only surpassed in some cases by 
arterial hypertension1. Although some cases of hypercholesterolemia are due to genetic alterations (mutations 
of APOB or low density lipoprotein (LDL) receptor genes)3, most of them are related to lifestyle factors, such as 
diet and exercise, and other related metabolic pathologies, such as overweight, obesity or diabetes4,5. Therefore, 
most therapeutic strategies currently used against hypercholesterolemia are a combination of lipid-lowering med-
ications and lifestyle modifications, especially dietary restrictions of fat and carbohydrates, addressed to reduce 
plasmatic lipids levels, whose main target is the levels of cholesterol carried by LDL (LDL-C)6–8. Other strategies 
are addressed to increase the levels of cholesterol carried by high density lipoprotein (HDL-C), which has been 
linked to a decrease in cardiovascular (CV) events. However, all these strategies have lower efficacy than expected, 
probably due to wrong selection of the target or inter-individual responses related to physiology.
Regarding the former, in last years, some dynamic studies defend that the particle size (Z) of lipoprotein 
may be better predictive factor of CV events and therefore, they could be a better target for strategies against 
hypercholesterolemia. Thus, a higher amount of large-HDL particles (large-HDL-P) and a larger average size of 
HDL (HDL-Z) have been positively related to a decrease of CV events, and the amount of small HDL particles 
(small-HDL-P) with an increase9–12. Whereas, with respect to the latter, gut microbiota could be relevant, since its 
study in last decade have proposed it as a novel key player in this pathology. The human gut harbours about 100 
trillion of typically non-pathogenic microbes whose whole microbiome is closed to the staggering number of 5 
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million genes, which confers it a big capability to modify and regulate the host physiology. Increasing evidences, 
mainly from studies with germ free mice, support an important role of gut microbiota in host energy metabolism 
and blood lipid levels modulation13,14. These microbes and their metabolic products such as short chain fatty 
acids (SCFAs), or bile acids (BA), etc. have been reported to influence the efficiency of energy harvesting, as well 
as activate the immune system, modulate the chronic inflammation through the alteration of intestinal barrier 
permeability and disturb the reverse cholesterol transport among others, affecting therefore the susceptibility for 
certain metabolic disorders such as obesity, diabetes or alcoholic fatty liver disease15–21. However, despite all these 
great advances in the knowledge of host physiology microbiota involvement, there are still few studies in humans 
revealing both the identity of microbes and their metabolites associated with host lipid metabolism.
The aim of this study was to compare both the faecal microbiota composition and the SCFAs and BA profile 
of subjects with hypercholesterolemia (HC) and normocholesterolemia (NC) in order to determine whether 
hypercholesterolemia is associated with a particular faecal bacteria signature. In addition, correlations between 
these both parameters and a wide selection of lipid profile biomarkers, taking into account their particle size, were 
analysed.
Results
Serum lipid profile characterization of HC and NC. HC group displayed the typical hallmarks of this 
phenotype in comparison with NC group (Table 1), such as higher Total-C levels, mainly carried by interme-
diate-density lipoprotein (IDL-C) and LDL (LDL-C), higher levels of triglycerides (TG) from IDL and LDL, as 
well as higher ratio of both Total-C to HDL-C and LDL-P to HDL-P. With regard to the amount of lipoprotein 
particles classified accordingly their size, HC showed higher levels of both large, medium and small LDL particles 
(large-LDL-P, medium-LDL-P and small-LDL-P), although its average size (LDL-Z) were similar in both groups. 
Respect to HDL, the amounts of small particles (small-HDL-P) was also increased in HC, whereas the average 
diameter (HDL-Z) was slightly higher in NC. Nevertheless, APOA1 levels, the major component of HDL in 
plasma, did not present significant differences between both populations.
Diversity of faecal bacterial species in HC and NC. The assessment of bacterial species diversity did 
not display relevant differences between HC and NC subjects (Fig. 1A–D). Thus, the number of observed opera-
tional taxonomic units (OTUs) (HC, 380.1; NC, 368.3; p-value = 0.79) as well as the average of Chao’s index (HC, 
430.1 and NC, 412.1; p-value = 0.55) displayed analogous values in HC and NC subjects. Likewise, Shannon’s 
and Simpson’s indexes revealed a similar diversity in both groups (Shannon’s Index: HC, 3.92 and NC, 3.69, 
p-value = 0.37; Simpson’s Index: HC, 0.94 and NC, 0.92, p-value = 0.32).
Taxonomic characterization of the faecal bacterial community in HC and NC. Taxonomic char-
acterization analysis revealed some differences between the faecal bacterial communities of HC and NC sub-
jects (Fig. 1E–F, Supplementary Tables S1, S2). Particularly, at phylum level, these differences were observed 
among the tail of rare bacteria, since HC displayed less relative abundance of Tenericutes than NC (0.002% vs 
0.22%, respectively; p-value = 0.026, q-value = 0.2812). This differential taxonomic feature was maintained from 
phylum to genus level, thus HC showed reduced abundance of Mollicutes (Class), Anaeroplasmatales (Order), 
Anaeroplasmataceae (Family) and Anaeroplasma (0.002% vs 0.22%, p-value = 0.026; q-value = 0.8573).
No differences were observed in dominant phyla such as Bacteroidetes or Firmicutes (HC, 49.58% vs NC, 
51.13% and HC, 42.01% vs NC, 49.98%, respectively), and either in Proteobacteria (HC, 5.01% vs NC, 1.53%, 
respectively) (Fig. 1E). The ratio Firmicutes to Bacteroidetes, which has been reported to change through age22 
and in certain metabolic pathologies such as obesity23, was also similar in both groups (data not shown). 
Nevertheless, there were three bacterial genera belonging to these phyla which were found to have different prev-
alence in both groups: Odoribacter (Bacteroidetes), Ruminoccocus (Firmicutes) and Haemophilus (Proteobacteria), 
(Fig. 1F, Supplementary Tables S1, S2). Haempohilus displayed lower relative abundance in HC (HC, 0.04% vs 
NC, 0.08%, p-value = 0.049, q-value = 0.8573), whereas in contrary, the others showed higher relative abun-
dance in these subjects (Odoribacter, 0.51% vs 0.16% p-value = 0.044, q-value = 0.8573; Ruminococcus, 2.33% 
vs 1.12% p-value = 0.049, 0.8573). Only two species belonging to Phascolarctobacterium genus were observed 
differently represented in both groups (Supplementary Table S1), displaying less relative abundance in HC than 
in NC: P. faecium (1.32% vs 2.26%, p = 0.042, q-value = 0.764) and P. succinatutens YIT 12607 (1.18% vs 2.62, 
p-value = 0.046, q-value = 0.764).
Influence of diet and age over the observed faecal bacterial community composition in HC and NC. 
Diet is a key factor in gut microbiota shaping24. Therefore, its potential influence over the differences observed in 
the faecal bacterial composition between HC and NC subjects was studied. No differences were observed in the 
studied dietary parameters between both groups (Supplementary Table S3). Nevertheless, it was observed that 
Haemophilus correlated positively to saturated fatty acids levels (SFA), Odoribacter did negatively with both die-
tary energy and carbohydrates intake, and in the case of Ruminococcus, it correlated negatively to energy intake, 
fat, SFA and monounsaturated fatty acids (MFA). Anaeroplasma was not associated with any dietary parameter 
(Supplementary Fig. S1).
Age is another key factor in microbiota modulation. Particularly it has been shown that diversity changes 
through the different stages of life, remain almost stable during adulthood until old age25. In the present study, 
although age was significantly different between HC and NC when compared by Student-t test (Table 1), both 
groups were in the same range of age (adulthood), which was reflected by a similar faecal bacteria diversity. 
Nevertheless, with regard to the taxonomical differences observed, associations analysis revealed that the age 
correlated positively with Ruminococcus relative abundance (rho: 0.543, p-value = 0.002) (Supplementary Fig. S2), 
but not with the other genera (data not shown).
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HC NC p-value q-value
Demographic features
  N 21 9
  Sex Male Male
  Race Caucasian Caucasian
  Country Spain Spain
  Region Catalonia Catalonia
  Age (years) 54.5 ± 7.5 43.67 ± 7.48 0.0024 0.0114
Anthropometric data
  BMI (kg/m2) 28.4 ± 2.8 26.18 ± 5.37 0.0315 0.0883
  WHR 0.96 ± 0.04 0.91 ± 0.04 0.0080 0.0281
  Body fat percentage 26 ± 4.7 25.2 ± 6.7 0.7483 0.7483
  Biceps fold (mm) 8.0 ± 2.3 7.26 ± 3.41 0.2264 0.3169
  Triceps fold (mm) 14.6 ± 4.7 15.5 ± 7.2 0.6248 0.6248
  Subscapular fold (mm) 22.3 ± 6.4 21.17 ± 8.5 0.7182 0.7483
  Suprailiac fold (mm) 15.5 ± 5.4 11.4 ± 4.7 0.0563 0.0985
Blood pressure (mmHg)
  Systolic blood pressure 134.4 ± 17.4 119.56 ± 12.21 0.0401 0.0899
  Diastolic blood pressure 88.4 ± 11.2 80.89 ± 9.92 0.0945 0.1469
  Mean blood pressure 106.1 ± 27.6 100.22 ± 10.4 0.0449 0.0899
Blood biochemistry
  Glucose (mg/dL) 109.22 ± 9.78 97.6 ± 7.0 0.0025 0.0175
  Lactate (mg/dL) 26.6 ± 9.5 22.2 ± 11.8 0.3444 0.4822
  Uric acid (mg/dL) 5.9 ± 1.4 4.4 ± 0.4 0.0002 0.0024
Lipids
Cholesterol (C) (mg/dL)
  VLDL-C 16.93 ± 11.23 8.61 ± 4.35 0.0503 0.0795
  IDL-C 10.77 ± 4.28 6.8 ± 2.35 0.0022 0.0055
  LDL-C 123.32 ± 22.08 89.48 ± 16.73 <0.0001 0.0003
  HDL-C 51.61 ± 7.59 52.55 ± 9.13 0.8994 0.8994
  Total-C 202.62 ± 30.32 157.44 ± 24.14 0.0002 0.0009
Triglycerides (TG) (mg/dL)
  VLDL-TG 88.34 ± 58.2 47.06 ± 18.97 0.0503 0.0795
  IDL-TG 11.7 ± 3.47 8.31 ± 1.99 0.0027 0.0063
  LDL-TG 15.4 ± 4.78 9.57 ± 3.04 0.0003 0.0008
  HDL-TG 14.67 ± 4.91 12.32 ± 2.38 0.3722 0.4136
  Total-TG 130.12 ± 64.17 77.26 ± 21.46 0.0315 0.0676
Particle number (P)
  VLDL-P (nmol/L) 58.59 ± 40.55 30.35 ± 12.52 0.0563 0.0844
  Large VLDL-P (nmol/L) 1.8 ± 0.9 1.11 ± 0.5 0.0449 0.0795
  Medium VLDL-P (nmol/L) 8.7 ± 4.99 5.01 ± 1.75 0.0111 0.0208
  Small VLDL-P (nmol/L) 48.09 ± 34.96 24.23 ± 10.36 0.0627 0.0896
  LDL-P (nmol/L) 891.61 ± 161.53 637.23 ± 119.17 <0.0001 0.0003
  Large LDL-P (nmol/L) 108.36 ± 24.97 79.65 ± 16.69 0.0005 0.0014
  Medium LDL-P (nmol/L) 324.09 ± 72.68 230.39 ± 53.33 0.0006 0.0017
  Small LDL-P (nmol/L) 459.16 ± 81.6 327.19 ± 58.95 <0.0001 0.0003
  HDL-P (μmol/L) 29.14 ± 4.13 27.13 ± 3.33 0.2022 0.2426
  Large HDL-P (μmol/L) 0.19 ± 0.06 0.16 ± 0.05 0.2452 0.2829
  Medium HDL-P (μmol/L) 7.41 ± 2.25 8.51 ± 1.88 0.3375 0.375
  Small HDL-P (μmol/L) 21.54 ± 3.93 18.46 ± 2.1 0.02424 0.03463
Particle Diameter (Z)
  VLDL-Z (nm) 42.55 ± 0.56 42.8 ± 0.36 0.1623 0.2029
  LDL-Z (nm) 21 ± 0.2 21.02 ± 0.16 0.7558 0.7819
  HDL-Z (nm) 8.17 ± 0.06 8.22 ± 0.04 0.0387 0.05279
Other Parameters
  Non-HDL-P (nmol/L) 921.06 ± 167.78 640.45 ± 112.93 <0.0001 0.0001
  Total-P/HDL-P 32.92 ± 5.72 24.59 ± 2.94 <0.0001 0.0001
  LDL-P/HDL-P 30.93 ± 5.72 23.44 ± 3.06 <0.0001 0.0001
Continued
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Correlation between faecal bacterial community and serum lipid profile. In order to determine 
if there was some kind of association between the lipid profile and the faecal bacterial composition of the studied 
subjects, correlation analysis between both parameters, taking into account the four genera differently repre-
sented in HC and NC, were assessed by Spearman’s correlation method. As result, after correction for mul-
tiple testing; Aneroplasma (Tenericutes phylum), displayed a negative correlation with IDL-C, all biomarkers 
TG-related, total and medium very low density lipoproteins (VLDL) and the ratio Total-C to HDL-C (Fig. 2, 
Table S4). Haemophilus (Proteobacteria phylum) displayed a negative correlation to the same biomarkers, and 
also with Total-C, all biomarkers related to VLDL, and the total amount of non-HDL-P and LDL-P, particu-
larly, the medium and small-LDL-P, among others. In contrary, Odoribacter (Bacteroidetes phylum) displayed 
a positive correlation with almost all biomarkers mentioned above, including the ratio Total-C to HDL-C. 
Regarding the average size of lipoproteins, Odoribacter correlated negatively to HDL-Z, whereas Anaeroplasma 
and Haempohilus did positively. In the case of Ruminococcus (Firmicutes phylum), no significant correlations 
were observed.
Respect to the remaining genera identified in the studied subjects, Enterorhabdus and Turicibacter were the 
genera which showed correlation with more lipid biomarkers (Supplementary Fig. S3). Thus, Enterorhabdus dis-
played positive correlations with almost all VLDL related biomarkers and Total-TG, but negative to HDL-Z; 
whereas Turicibacter correlated negatively to IDL-TG, HDL-TG, Total-TG and with all VLDL-related biomarkers, 
but positive to HDL-Z.
Faecal bacterial co-occurrence. The effect of microbiota on human metabolism depends on both synergist 
and antagonist effects between the present microbes of the community rather than to the behaviour of a particular 
microbe. Therefore, co-occurrence between discriminant bacteria genera in HC and C and the remaining bac-
teria was also study (Table S5). Anaeroplasma showed correlations with seven genera, among which Acetivibrio, 
Desulfovibrio, Oxolobacter and Roseburia correlated also with lipid profile. Haemophilus, it was found to correlate 
with Desulfovibrio, Slackia and Veillonella among others. Odoribacter abundance seemed to be associated with six 
genera, among which were Ruminococcus, the genus associated with more bacteria.
Bacterial fermentation products profile characterization and correlation with lipid profile. 
SCFAs are secondary metabolites resulting from bacterial action on diet indigestible fraction that may influence 
host metabolism26. Thus, a faecal dysbiosis may involve an alteration in SCFAs profile that could alter the host 
lipid metabolism. Therefore, the levels of most common SCFAs present in faeces (acetic, propionic and butyric 
acid), as well as isobutyric and isovaleric acids, were assessed in faecal and serum samples. Succinic acid levels 
were also analysed in faeces, since it is an organic acid commonly present as result of bacterial activity.
The results from the faecal samples revealed that the total SCFAs and succinic acid levels were similar in HC 
and NC (Fig. 3A,C). However, in terms of proportions, both isobutyric (2.76% vs 0.82%, p-value = 0.049) and 
isovaleric acid (1.32% vs 0.06%, p-value = 0.016) displayed higher abundance in HC than NC (Fig. 3B), whereas 
acetic, propionic and butyric acids levels were not different between both groups.
In order to study whether the higher proportion of both isobutyric and isovaleric acid in faeces from HC 
versus NC was related to the differences observed in bacteria composition and lipid profile, correlation analy-
sis between them were performed. Results revealed that the isobutyric acid proportion was positively associ-
ated with Odoribacter and Ruminococcus abundances (Fig. 3D–E). Isovaleric acid did not show association with 
these genera. In relation to blood lipid profile, isobutyric acid seemed to correlate positively with LDL-C, LDL-P, 
medium-LDL-P and the ratio LDL-P/HDL-P, and negatively with HDL-Z (Fig. 4A–D, Table S6). With respect to 
the other SCFA, it was observed a positive correlation between acetic acid and IDL-C, whereas propionic acid 
correlated negatively to this last biomarker and also with the large HDL-P levels (Fig. 4A–D, Table S6). No corre-
lations were observed with butyric and isovaleric acids.
Serum SCFAs profile characterization revealed that, as well as in faeces, the total SCFAs levels were similar in 
HC and NC (Supplementary Fig. S4A). Among the SCFAs detected, only butyric acid showed different levels in 
HC and NC, being more abundant in the latter (15.0 vs 19.0 µmol/L, p-value = 0.0021) (Supplementary Fig. S4B). 
Isovaleric acid was not detected. Correlation analysis revealed that serum levels of butyric acid correlated nega-
tively to several lipid biomarkers, most of them related to low density lipoproteins levels such as LDL-C, LDL-TG, 
large and small-LDL-P, as well as Total-C and Total-C to HDL-C ratio among others (Supplementary Fig. S4C). 
Serum levels of acetic acid and the total amount of SCFAs correlated positively to APOA-1 levels, whereas isobu-
tyric levels were observed to correlated negatively to LDL-C. No correlations with propionic acids levels were 
observed.
Other metabolites from bacteria activity in the gut are the secondary products from cholesterol and BA18, 
so thus their abundance and composition are linked to bacteria community presence and, presumably, its 
HC NC p-value q-value
  Total-C/HDL-C 3.97 ± 0.64 3.02 ± 0.3 <0.0001 0.0001
  ApoA1 (mg/dL) 136.68 ± 22.07 142.49 ± 22.84 0.5291 0.5669
Table 1. Demographic, anthropometric and biochemical features of HC and NC subjects. Mean and standard 
deviation of each numeric variable are shown. p-value and q-value obtained after adjustment for multiple 
testing are shown. q-values < 0.05 are indicated in bold. Abbreviations used: BMI (body mass index), WHR 
(waist to hip ratio), very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), low density 
lipoprotein (LDL), high density lipoprotein (HDL).
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composition. According to this and due to their relation to the host lipid profile, the abundance of these metab-
olites in the faeces of HC and NC, as well as their potential associations with the discriminant genera observed 
among both groups, was assessed. The results revealed that total levels of sterols in faeces of HC and NC were 
similar (Supplementary Fig. S5A). Specifically, both cholesterol and their derived metabolites showed similar 
values in both groups. Likewise, the analysis of BA profile revealed that the amount of chenodeoxycholic acid 
(CDCA), cholic acid (CA), lithocholic acid (LCA) and deoxycholic acids (DCA) were similar in the faeces of HC 
and NC (Supplementary Fig. S5B). Correlation analysis revealed some associations between the discriminant 
genera and these metabolites. Thus, Haemophilus was observed to be negatively associated with the levels of total 
sterols, coprostanol and DCA, whereas Odoribacter and Ruminococcus were both negatively associated with cho-
lesterol levels and positively to coprostanol, and in case of the latter, cholestanol too (Supplementary Fig. S5C). 
Anaeroplasma, however, did not show correlation with sterols or BA.
Figure 1. Species diversity and faecal bacterial taxonomic signature in HC versus NC subjects. Diversity 
indexes: (A–D) Observed OTUs, Chao1, Shannon’s and Simpson’s indexes, respectively. (E) Pie chart of phyla 
relative abundances identified in HC and NC, respectively. (F) Cladogram plot of discriminant taxa identified 
by LEfSe analysis, p-value < 0.05 as significant.
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Figure 2. Correlation between serum lipid biomarkers and differential genera in HC and NC subjects. 
Correlation with (A) cholesterol-related biomarkers, (B) triglyceride-related biomarkers, (C) lipoprotein 
ratios and APOA-1 and (D) lipoprotein particles classified according their size. Correlations were assessed 
considering data from both groups together. Correlations with q-values below 0.15 after adjustment for multiple 
analysis are highlighted with an ellipse. The colour and slope of the ellipse indicate magnitude of correlation, 
with Spearman’s rho value superimposed on the ellipse. The ellipses of positive correlations are shown in blue 
and the negative correlations in red. Correlations with q-values > 0.15 are in white.
Figure 3. Faecal bacterial fermentation products profile in HC and NC subjects and significant correlation 
with bacterial abundance at genus level. (A–C) Total SCFAs, SCFAs profile and succinic acid levels, respectively. 
P-value < 0.05 after comparison between HC and NC are indicated. (D,E) Correlation plots of isobutyric acid 
with the genera Odoribacter and Ruminococcus, respectively. Spearman’s rho and q-value are shown.
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Discussion
Gut microbiota has been suggested to play an important role in host’s metabolism, including lipid levels mod-
ulation20,27. One of the main contributions of the present work to this issue is the proposal of a specific faecal 
bacteria signature in individuals with hypercholesterolemia, characterized by lower relative abundance of both 
Anaeroplasma (Tenericutes) and Haemophilus (Proteobacteria) and higher relative abundance of both Odoribacter 
(Bacteroidetes) and Ruminococcus (Firmicutes) compared with normomocholesterolemic subjects. These differ-
ences seem to be intrinsically related to the subject physiology rather than to other external factors that have been 
reported to alter the gut microbiota composition, such as diet; since although some association were observed 
between both carbohydrates, fat, MFA and SFA with Haemophilus, Odoribacter and Ruminococcus, the intake of 
these nutrients was similar in HC and NC. Only in the case of Ruminococcus, the differences observed were asso-
ciated with age, so that further studies in a large cohort would be needed to confirm or discard its contribution to 
the faecal bacterial signature in this pathology.
In another context, Tenericutes and Odoribacter seem to have a high heritability, as has been recently reported 
in a study performed on monozygotic and dizygotic twins and their families28. Their alterations have been also 
described in other metabolism-related pathologies such as obesity, metabolic syndrome and diabetes21,29, sug-
gesting that the dysbiosis of these bacteria in HC subjects could have a certain hereditary component which is 
common to other metabolic disorders as well. In fact, patients with phenylketonuria, an inborn metabolic error, 
have been reported to have lower Odoribacter and Ruminococcus abundance30 and interestingly, a study addressed 
by Moseley revealed that almost 26% of phenylketonuria patients had blood lipid profile alteration31. In the case 
of Haemophilus, a genus which includes some species related to pathogenicity, it is unknown which factors may 
modulate their population, although its decline has been also reported in other metabolic disorders such type II 
diabetes32.
Furthermore, correlation analysis with serum lipid biomarkers support and stand out the relevance of these 
bacteria in hypercholesterolemia. Particularly, in the case of Haemophilus, a negative correlation with a com-
mon indicator of dyslipidaemia such as the Total-C to HDL-C ratio was observed, but also with TG and novel 
Figure 4. Faecal bacterial fermentation products profile and lipid biomarkers association in HC and NC 
subjects. Correlation with cholesterol-related biomarkers (A), triglyceride-related biomarkers (B), lipoprotein 
ratios and APOA-1 (C), and lipoprotein particles classified according their size (D). Correlations were assessed 
considering data from both groups together. Correlations with q-values below 0.15 after adjustment for multiple 
analysis are highlighted with an ellipse. The colour and slope of the ellipse indicate magnitude of correlation, 
with Spearman’s rho value superimposed on the ellipse. The ellipses of positive correlations are shown in blue 
and the negative correlations in red. Correlations with q-values > 0.15 are in white.
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biomarkers related to lipoprotein size, such as the average size of HDL, or the amount of small-LDL-P, which 
has been recently reported to be associated with a higher incidence of peripheral artery disease in women33. 
These findings are consistent with results recently reported by Fu and colleagues, in which bacteria of the family 
to which this genus also belongs (Pasteurellaceae) showed a negative correlation to TG levels27. Similarly, it was 
observed that the lower abundance of Anaeroplasma, was associated with an unfavourable lipid profile (IDL-C, 
TG-related biomarkers and the ratio Total-C to HDL-C among others). Previous studies had already reported 
an association between both TG and HDL levels with Tenericutes phylum, but until now it was unknown which 
bacteria from this phylum showed this sort of correlation34. With regard to Odoribacter, the lower abundance, the 
better lipid profile was observed, since it displayed a positive correlation to both IDL-C and IDL-TG, Total-TG, 
VLDL-P and the ratio of Total-C to HDL-C, among others. These results are consistent with previous data of Fu 
and colleagues, suggesting a negative correlation of this genus to HDL-C27, as well as a positive association with 
other related metabolic parameters such as the body fat percentage, adiposity index and visceral fat29.
Moreover, another interesting point that highlights the relevance of these four genera in dyslipidaemia is the 
fact that they seem to influence on the abundance of other bacteria such as Slackia, Desulfovibrio, Oxalobacter, 
Roseburia, Oscillibacter, Parabacteroides and Turicibacter; which according to results from this study are also 
associated with blood lipid levels.
At species level, HC seem to have a lower relative abundance in Phascolarctobacterium faecium and 
Phascholarctobacterium succinatutens YIT12067. Both are bacteria that mainly use succinate as energy source35, 
which suggests that differences in this energy source could lead to differences in their abundances. However, in 
the present work, the levels of succinic acid in faeces were similar in HC and NC subjects. P. succinatutens has 
been described as a kind of bacteria unable to grow in presence of bile acids35, so that its lower abundance in HC 
individuals could be associated with an increase of faecal bile acids. Nevertheless, results of this work revealed 
that the amount of bile acids in the faeces of HC and NC were similar.
One of the main mechanism by which gut microbiota may influence on host physiology is linked to their 
metabolic activity26,36. The major end products of bacterial fermentation in colon are organic acids such as acetate, 
propionate, butyrate, lactate and succinate, together with hydrogen, methane and CO237. Mounting evidences 
suggest that SCFAs have a high impact on host physiology since they can act as energy source for epithelial cells, 
signalling molecules and gene expression modulator26,36,38. The amount and relative abundance of each SCFA 
depend on diet’s indigestible fraction24,38, but also on a cross-feeding mechanisms established in the bacterial 
community39,40. The most abundant SCFAs are acetic acid (C2), propionic acid (C3) and butyric acid (C4), which 
together represent nearly 90–95% of the SCFA present in the colon41. Acetate is a net product of carbohydrate 
fermentation of most anaerobes bacteria, while propionic and butyric acid are generated from carbohydrate or 
protein fermentation by a distinct subset of bacteria42. In the present study, both faecal and serum total SCFAs 
were similar in HC and NC. Nevertheless, data from correlation analysis revealed that the faecal proportion of 
acetic acid correlated positively to IDL-C levels, whose high levels are indicative of a more unfavourable lipid 
profile, while propionic acid did negatively. The serum levels of acetic and propionic acids, although were not sig-
nificantly different between groups, displayed a profile characterized by higher and lower abundance of acetic and 
propionic acids, respectively, in HC than NC. These findings are consistent with data from previous studies show-
ing that circulating acetic acid is related to “de novo” lipogenesis and cholesterogenesis stimulation in the liver, 
while propionic acid seemed to inhibit them43,44, which reinforced the hypothesis that the ratio of acetic acid to 
propionic acid could be considered as a novel biomarker of the host lipid profile status. Nevertheless, with regard 
to the role of acetic acid in lipid metabolism there are some controversies, since other authors have reported 
that dietary acetic acid is related to a decrease of both cholesterol and triglyceride levels in rats45. Abundance 
of butyrate in faeces did not show difference between HC and NC and showed no correlation with any of the 
analysed lipid biomarkers in the present study. However, its serum levels were higher in NC, revealing a negative 
correlation to lipids related to a worst profile, such as LDL-C, Total-C, LDL-TG, LDL-P (large and small) and 
Total-C to HDL-C ratio among others. Nevertheless, previous studies have reported that butyrate stimulates fatty 
acid synthesis and cholesterogenesis46. Contrary, an interesting paper published by Gao Z et al. reported that 
supplementation of butyrate in diet is able to prevent other metabolic pathologies such as insulin resistance in rat, 
associated to a mechanism of energy expenditure and induction of mitochondrial function47.
The last relevant finding from this study revealed the role of isobutyric and isovaleric acids in human lipid 
metabolism. Both are considered branched short chain fatty acids (BSCFAs). They can be generated from valine 
and leucine fermentation26,48–50 and only contribute to 5% of the total SCFAs production. Data from the present 
work, revealed that the proportion of both BSCFAs seemed to be higher in HC than in NC, suggesting an increase 
of amino-acid fermentation in this group which in turn, strengthens the accumulation of other potentially harm-
ful metabolites such as indole, amines, p-cresol or ammonia among others51,52. According to this, in the present 
study, isobutyric acid was observed to be associated with a more unfavourable lipid profile, since the higher levels 
of this BSCFA, the higher values of LDL-C, total LDL-P, medium-LDL-P, LDL-P/HDL-P ratio, Total-C/HDL-C 
ratio and lower HDL-Z were observed. These data are consistent with previous studies reporting cAMP-mediated 
lipolysis inhibition and insulin-stimulated de novo lipogenesis in primary rat adipocytes by BSCFA53. The dif-
ferential production in BSCFA could be explained by the difference in bacterial relative abundance. Most of 
proteolytic bacteria reported in literature belong to Bacteroides and Clostridium genera37. However, none of 
them was differently represented in HC and NC. Instead, the genera Odoribacter, from which some species have 
been related to isovaleric acid production54, and Ruminococcus, which has been reported to required BSCFA 
for growth55,56 were found to be more abundant in HC than in NC, and both showed a positive correlation with 
isobutyric proportions observed in faeces.
The activity of faecal bacteria is also related to both bile acids and cholesterol metabolization, whose 
derived products may influence host lipid metabolism18. Results from this work revealed that Odoribacter 
and Ruminococcus were negatively associated with faecal cholesterol levels and positively to coprostanol and 
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cholestanol, that might indicate a higher metabolism of this sterol in HC. However, the similarity in the abun-
dance of coprostanol and cholestanol in the faeces of HC and NC ruled this hypothesis out. Likewise, Haemophilus 
displayed a negative association with DCA, but the levels of the bile acids were similar in both groups, discarding 
that the relation between the lipid profile and the discriminant bacteria observed in both groups was due to these 
metabolites.
Remarkable conclusions. This study revealed that individuals with hypercholesterolemia possess 
a particular faecal bacterial signature, characterized by lower prevalence of the genera Anaeroplasma and 
Haemophilus and higher prevalence of Odoribacter, which seems to be associated with a wide range of blood 
lipid biomarkers, including those ones commonly linked to a higher risk of CVDs and others considered as 
novel promising biomarkers related to both amount and size of lipoproteins. Furthermore, it was observed in HC 
subjects a raise in isobutyric acid, whose higher abundance in the faeces could be considered as a biomarker in 
hypercholesterolemia.
The lower prevalence of both P faecium and P Succinatutens in the faeces of hyperhcolesterolemic subjects is 
suggested as another hallmark of the bacterial community dysbiosis associated with higher cholesterol levels but 
its involvement in the lipid profile is still unclear.
Nonetheless, in spite of the relevant findings here shown, the authors assume that the study has some lim-
itations. It was performed only in men, all of them from a specific area of Spain (Catalonia), the number of 
subjects was low and moreover, the number of healthy volunteers was lower than the hypercholesterolemic ones. 
Methodologically, 16S rRNA sequencing data has been a revolutionary technique in last years, but it has some 
limitations related to detection at species level with respect other methods more expensive currently used. To con-
firm these results, mainly descriptive, further studies addressed to perform microbiota colonization of germ-free 
mice through the administration of faeces from volunteers with normo- and hypercholesterolemia would be 
appropriated.
Methods
Subjects and study design. In total, 30 men aged between 35–65 years from Lleida (Spain), whose demo-
graphic data are provided in Table 1, participated in the study. Due to the reported influence of androgens on 
the lipid profile, women were not included in this study. Volunteers with known history of hypercholesterolemia 
were recruited from Primary Care Centres in Catalonia, with the collaboration of Centre’s Family Physicians. 
More than 3 blood test analyses that revealed high levels of total cholesterol (>200 mg/dL) was used as defining 
criteria for the hypercholesterolemic phenotype. The exclusion criteria included a body mass index (BMI) out 
of the range 25–35 kg/m2, suffering metabolic pathologies such as type 1 or type 2 diabetes and having taken 
lipid-lowering medications, probiotic supplements and/or antibiotics in last two months. Volunteers with no 
history of high levels of total cholesterol (<200 mg/dL) were selected as control group. All volunteers were ade-
quately informed before giving their consent and no one of them have taken any medications. The study, whose 
experimental design is shown in Fig. 5, was approved by the clinical research ethical committee of the Institut 
Catalá de Salut from Hospital Universitary Arnau de Vilanova, in Lleida, Spain (CEIC-1534. 21/12/2015) and it 
was conducted according to the ethical guidelines of the Helsinki Declaration.
Figure 5. Study design flowchart.
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Blood biochemistry. Venous blood samples from each volunteer in fasting conditions (12 hours) were col-
lected in serum separator tubes (BD, Ref. 367953) and centrifuged immediately for 15 min at 4 °C at 1500 g. Then, 
the serum was collected and kept at −80 °C until the further biochemical analysis. Total-C and TG levels, as well 
as their content in lipoproteins (VLDL, IDL, HDL, LDL) and the average size of each particle were measured 
through Liposcale test by the Research Unit on Lipids and Atherosclerosis of Sant Joan University Hospital and 
Universitat Rovira i Virgili, at Reus (Spain), according to the procedures described by Mallol and colleagues57. 
APOA1 levels as well as glucose, lactate and uric acid were quantified by SPINREACT kits following manufactur-
er’s instructions (Ref. 93010, 1001010, 1001190, 1001330, respectively).
Microbial DNA purification, 16S amplicon preparation, sequencing and processing. In order 
to characterize the faecal bacterial community of both hypercholesterolemic and healthy volunteers, they were 
asked for a single stool sample produced at any time of the day before to the blood extraction, with no spe-
cific dietary restrictions, which were collected in sterile plastic containers (Deltalab, Ref. 4097226) and kept at 
−20 °C until their delivery the day after. Once in the laboratory, samples were divided in aliquots of approximately 
180–220 mg and frozen at −80 °C until further analysis. Microbial DNA was extracted from the stool samples 
using the QIAamp DNA Stool Mini Kit (Qiagen, Hilden, Germany, Ref. 51504) as described per manufacturer’s 
instructions with a slight modification which included a previous bead-beating step (1 cycle of 40 seconds at 4 °C) 
in Lysing Matrix E tubes for FastPrep 24 (MP Biomedicals, 11452420). DNA quality and yield were evaluated via 
1% (w/w) agarose gel electrophoresis and NanoDrop 2000 UV spectrophotometer (Thermo Fisher Scientific, 
Waltham, MA, USA).
The 16S rRNA gene libraries were generated by the company Vaiomer in Toulouse (France). Briefly, bacterial 
populations were determined using next generation high throughput sequencing of variable regions of the 16S 
rDNA bacterial gene using 16S universal primers targeting the V3-V4 region of the bacterial 16S ribosomal gene. 
The joint pair length was set to encompass 476 base pair amplicon thanks to 2 × 300 paired-end MiSeq kit V3. 
For each sample, a sequencing library was generated by addition of sequencing adapters. The detection was per-
formed using MiSeq Illumina technology.
The targeted metagenomics sequences from microbiota were then analysed using the bioinformatics pipe-
line established from the FROGS v1.3.0 guidelines, and clustered into OTUs with the Swarm algorithm before 
taxonomic assignment as described by Lluch and colleagues58. Briefly, OTUs identified as chimera (with vsearch 
v1.9.5) in all samples in which they were present, with a relative abundance lower than 0.005% regarding the 
whole dataset, or with a strong similarity (coverage and identity ≥80%) with the phiX (library used as a control 
for Illumina sequencing runs) were removed. Clustering was produced in two passes of the swarm algorithm 
v2.1.6. The first pass was a clustering with an aggregation distance equal to 1 and the second one, equal to 3. The 
taxonomic assignment was produced by Blast+ v2.2.30+ with the databank RDP v11.4. In total, 997 OTUs were 
available for further analysis after filtering.
Bacterial analysis from 16S rRNA data. Species diversity. Species diversity of the faecal bacteria com-
munity in each population was assessed through several indexes:(1) the number of different taxa observed (OTUs 
observed), which refers the actual richness observed, (2) Chao1 index, which estimates the richness of a com-
munity based upon the number of rare species that may have been missed due to under-sampling, (3) Shannon’s 
index, that represents the average certainty to predict the identity of unknown individuals and (4) Simpson’s 
index that is based upon the probability that two individuals randomly selected will belong to the same species. 
Results were plotted by GraphPad Prism (version 5.0).
Taxonomic composition of faecal microbiota profile. To statistically test for discriminant taxon between HC and 
NC, OTUs data from each group were compared by LEfSe (linear discriminant analysis effect size) algorithm 
according as described by Segata and colleagues59 in Galaxy/Metabiome portal, with a p-value < 0.05 as signifi-
cant. Results were plot on a Cladogram. Moreover, differences in the relative abundance of each bacterial taxon 
(phylum, class, order, family, genus and species) were also assessed by the function runWilcox in R environment 
in order to obtain the p-value adjustment of each comparison for multiple testing (q-value).
Faecal and serum short-chain fatty acids profile. The SCFAs profile present in the faeces and serum 
of every volunteer and succinic acid levels were determined by high-performance liquid chromatography 
(HPLC-VWD) according to the method previously described by Torii and colleagues60, where SCFAs were 
detected as acid hydrazides at 400 nm. Briefly, succinic and five SCFAs were assessed: acetic, propionic, butyric, 
isobutyric and isovaleric acids. In the extraction of SCFAs from faeces, a sample of approximately 200 mg previ-
ously frozen at −80 °C was contained in a weighed glass centrifuge tube and 5.0 mL of 70% ethanol was imme-
diately added. The tube was weighed to determine the faecal weight, followed by mixing and centrifugation at 
20 °C, 2500 rpm for 10 min. The supernatant was collected as analytical sample. Then each sample (300 µL) were 
derivatized with 50 µL of 2-ethylbutyric acid as internal standard and 300 µL each of pyridine, 1-EDC-HCl and 
2-NPH-HCl as reaction-assistive agents, reacted at 60 °C for 20 min, and then mixed to 200 µL potassium hydrox-
ide as reaction stopper and reacted at 60 °C for 20 min. After cooling the mixture was shaken with 3 mL of phos-
phoric acid aqueous solution and 4 mL of ether for 3 min for extraction and centrifuged. The obtained ether layer 
was shaken with 4 mL of water for 3 min and centrifuged. The ether layer was obtained, and ether was eliminated 
using nitrogen gas. Finally, the obtained fatty acid hydrazide was dissolved in 100 µL of methanol, and 30 µL was 
subjected to HPLC. All standards and reagents were purchased from Sigma-Aldrich. Analysis was performed 
using an HPLC of Agilent Technologies Serie 200 and a YMC-Pack FA 250 × 6 mm ID column. During the anal-
ysis, the column temperature was 50 °C; flow rate, 1.1 mL/min; and measurement wavelength 400 nm.
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SCFAs levels in serum were assessed following the same protocol mentioned above and extracted with ethanol 
and trichloroacetic acid 5%.
Faecal sterols and bile acids profile. Silylation of biliary acids and sterols was carried out according to 
Mosele and colleagues61, with some modifications. Briefly, 100 µL of pyridine (containing 50 µg/mL 5α-cholestan 
and 5β-colanic acid as internal standards) and 200 µL of N-methyl-N- (trimethylsilyl) trifluoroacetamide (both 
from Sigma-Aldrich) were added to vials containing 10 mg of faeces, vortexed and then maintained during 30 min 
at 60 °C. After silylation, samples were centrifuged 10 min at 8784 g at room temperature. The supernatants were 
analyzed by GC system (Agilent 6890 N) coupled to a mass spectrometer (Agilent 5973). Samples were injected 
into a capillary column DB-1MS (30 m × 0.25 mm, 0.10 μm, J&W, Agilent) and the analysis of biliary acids and 
sterols was performed as follows. Helium was the carrier gas (1 mL/min). Injection was carried out with a split 
injector (1:10) at 250 °C. The column temperature started at 240 °C and was raised at a rate of 20 °C/min until it 
reached 290 °C and maintained for 2 min, raised to 295 °C at a rate of 1 °C/min, and then raised at a rate of 20 °C/
min to 240 °C, and maintained for 3 min (total run time 20.1 min). Peak identification was based on comparison 
of retention times and mass fragmentation patterns with reference compounds. All quantifications were per-
formed in selected ion monitoring (SIM) mode using calibration curves generated from different know concen-
trations of commercial standards. For faecal biliary acids and sterols quantifications, commercial standards of 
cholic acid, deoxycholic acid, chenodeoxycholic acid, lithocholic acid, cholesterol, coprostanol and cholestanol 
(Sigma-Aldrich) were used.
Food habits registration, blood pressure and anthropometric measurements. The day of blood 
extraction and faecal samples delivery, with the collaboration of trained dieticians, volunteers were asked for 
a 24-hours dietary recall of the previous day. Then, both the amount of nutrients daily ingested by each vol-
unteer and the total energy food were estimated through DIAL software (Alceingeniería, S.A. Madrid, Spain). 
Additionally, blood pressure was taken using an automatic blood pressure cuff and anthropometric measure-
ments were performed. Weight and height were measured using a portable weighting scale with an accuracy of 
0.1 kg, and an incorporated steel ruler for making the size. The skinfolds thickness and estimation of total body fat 
were measured with a calliper, with an accuracy of 0.1 mm. The remaining anthropometric measurements were 
performed using a flexible measuring tape with an accuracy of 0.1 cm.
statistical Analysis. Statistical comparison of bacterial taxons between the two studied groups were per-
formed by LEfSe analysis in Galaxy/Metabiome portal. Moreover, relative abundances were compared with 
the function runWilcox from EMA package in R environment, which adjusts the p-value for multiple testing. 
Diversity indexes and metadata (lipid biomarkers, anthropometric data, dietary parameters, SCFAs, sterols and 
BA) were compared by unpaired t-test or Wilcoxon Mann-Whitney U test in R environment, considering a 
p-value < 0.05 as significant. P-adjustment after false discovery rate correction from multiple comparisons was 
performed with runTtest or runWilcox function when more than 10 variables of the same family data set were 
evaluated, and q-values were added. Correlation analysis was calculated by Spearman’s correlation method in R 
statistical framework using the cor.test function from the stats package corrplot. P-values were adjusted for mul-
tiple comparisons. q-value considered as significant is indicated in the legend of each figure. Results were plotted 
in R environment using the ellipse package or with GraphPad Prism (version 5.0).
References
 1. Mendis, S., Puska, P. & Norrving, B. Global Atlas On Cardiovascular Disease Prevention And Control. (ed. Mendis, S., Puska, P. & 
Norrving, B.) 1–164 (Geneva: World Health Organization in collaboration with the World Heart Federation and the World Stroke 
Organization, 2011).
 2. Millan Nuñez-Cortes, J. et al. Documento Abordaje de la dislipidemia. Sociedad Española deArteriosclerosis (parte III). Clin. e 
Investig. en Arterioscler. 24, 102–107 (2012).
 3. Sharma, K. & Baliga, R. R. Genetics of Dyslipidemia and Ischemic Heart Disease. Curr. Cardiol. Rep. 19, 46 (2017).
 4. Yusuf, S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART 
study): case-control study. Lancet (London, England) 364, 937–52 (2004).
 5. De la Sierra, A. et al. Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences 
from a Systematic Literature Review in Spain. Adv. Ther. 32, 944–61 (2015).
 6. Griffin, B. A. Nonpharmacological approaches for reducing serum low-density lipoprotein cholesterol. Curr. Opin. Cardiol. 29, 
360–5 (2014).
 7. McKenney, J. M. Lipid management: tools for getting to the goal. Am. J. Manag. Care 7, S299–306 (2001).
 8. Garg, A. & Simha, V. Update on dyslipidemia. J. Clin. Endocrinol. Metab. 92, 1581–9 (2007).
 9. Li, J.-J. et al. Large HDL Subfraction But Not HDL-C Is Closely Linked With Risk Factors, Coronary Severity and Outcomes in a 
Cohort of Nontreated Patients With Stable Coronary Artery Disease. Medicine (Baltimore). 95, e2600 (2016).
 10. Pérez-Méndez, Ó., Pacheco, H. G., Martínez-Sánchez, C. & Franco, M. HDL-cholesterol in coronary artery disease risk: Function or 
structure? Clin. Chim. Acta 429, 111–122 (2014).
 11. Xu, R.-X. et al. High-density lipoprotein subfractions in relation with the severity of coronary artery disease: A Gensini score 
assessment. J. Clin. Lipidol. 9, 26–34 (2015).
 12. Ramasamy, I. Update on the laboratory investigation of dyslipidemias. Clin. Chim. Acta, https://doi.org/10.1016/j.cca.2018.01.015 
(2018).
 13. Mestdagh, R. et al. Gut Microbiota Modulate the Metabolism of Brown Adipose Tissue in Mice. J. Proteome Res. 11, 620–630 (2012).
 14. Velagapudi, V. R. et al. The gut microbiota modulates host energy and lipid metabolism in mice. J. Lipid Res. 51, 1101–12 (2010).
 15. Kasubuchi, M., Hasegawa, S., Hiramatsu, T., Ichimura, A. & Kimura, I. Dietary Gut Microbial Metabolites, Short-chain Fatty Acids, 
and Host Metabolic Regulation. Nutrients 7, 2839–2849 (2015).
 16. Microbiota, G. I. GI Microbiota and Regulation of the Immune System. 635 (2008).
 17. Fiorucci, S. & Distrutti, E. Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders. Trends 
Mol. Med. 21, 702–714 (2015).
www.nature.com/scientificreports/
1 2Scientific RepoRts |          (2019) 9:1772  | https://doi.org/10.1038/s41598-019-38874-3
 18. Staley, C., Weingarden, A. R., Khoruts, A. & Sadowsky, M. J. Interaction of gut microbiota with bile acid metabolism and its influence 
on disease states. Appl. Microbiol. Biotechnol. 101, 47–64 (2017).
 19. Koeth, R. A. et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19, 
576–585 (2013).
 20. Allayee, H. & Hazen, S. L. Contribution of Gut Bacteria to Lipid Levels: Another Metabolic Role for Microbes? Circ. Res. 117, 750–4 
(2015).
 21. Ghazalpour, A., Cespedes, I., Bennett, B. J. & Allayee, H. Expanding role of gut microbiota in lipid metabolism. Curr. Opin. Lipidol. 
27, 141–7 (2016).
 22. Mariat, D. et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 9, 123 (2009).
 23. Koliada, A. et al. Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. BMC 
Microbiol. 17, 120 (2017).
 24. Simpson, H. L. & Campbell, B. J. Review article: Dietary fibre-microbiota interactions. Aliment. Pharmacol. Ther. 42, 158–179 
(2015).
 25. Dinan, T. G. & Cryan, J. F. Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. J. 
Physiol. 595, 489–503 (2017).
 26. Morrison, D. J. & Preston, T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut 
Microbes 7, 189–200 (2016).
 27. Fu, J. et al. The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids. Circ. Res. 117, 817–24 
(2015).
 28. Lim, M. Y. et al. The effect of heritability and host genetics on the gut microbiota and metabolic syndrome. Gut 66, 1031–1038 
(2017).
 29. Bressa, C. et al. Differences in gut microbiota profile between women with active lifestyle and sedentary women. PLoS One 12, 
e0171352 (2017).
 30. Pinheiro de Oliveira, F. et al. Phenylketonuria and Gut Microbiota: A Controlled Study Based on Next-Generation Sequencing. PLoS 
One 11, e0157513 (2016).
 31. Moseley, K., Koch, R. & Moser, A. B. Lipid status and long-chain polyunsaturated fatty acid concentrations in adults and adolescents 
with phenylketonuria on phenylalanine-restricted diet. J. Inherit. Metab. Dis. 25, 56–64 (2002).
 32. Zhang, X. et al. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One 8, e71108 (2013).
 33. Aday, A. W. et al. Lipoprotein Particle Profiles, StandardLipids, and Peripheral Artery Disease Incidence - Prospective Data from the 
Women’s Health Study. Circulation circulationaha. 118, 035432 (2018).
 34. Goodrich, J. K. et al. Human Genetics Shape the Gut Microbiome. Cell 159, 789–799 (2014).
 35. Watanabe, Y., Nagai, F. & Morotomi, M. Characterization of Phascolarctobacterium succinatutens sp. nov., an asaccharolytic, 
succinate-utilizing bacterium isolated from human feces. Appl. Environ. Microbiol. 78, 511–8 (2012).
 36. Ríos-Covián, D. et al. Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health. Front. Microbiol. 7, 185 (2016).
 37. Shen, Q., Chen, Y. A. & Tuohy, K. M. A comparative in vitro investigation into the effects of cooked meats on the human faecal 
microbiota. Anaerobe 16, 572–577 (2010).
 38. Koh, A., De Vadder, F., Kovatcheva-Datchary, P. & Bäckhed, F. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as 
Key Bacterial Metabolites. Cell 165, 1332–1345 (2016).
 39. Rios-Covian, D., Gueimonde, M., Duncan, S. H., Flint, H. J. & De los Reyes-Gavilan, C. G. Enhanced butyrate formation by cross-
feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiol. Lett. 362, fnv176 (2015).
 40. Hoek, M. J. Avan & Merks, R. M. H. Emergence of microbial diversity due to cross-feeding interactions in a spatial model of gut 
microbial metabolism. BMC Syst. Biol. 11, 56 (2017).
 41. Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P. & Macfarlane, G. T. Short chain fatty acids in human large intestine, 
portal, hepatic and venous blood. Gut 28, 1221–7 (1987).
 42. Louis, P. & Flint, H. J. Formation of propionate and butyrate by the human colonic microbiota. Environ. Microbiol. 19, 29–41 (2017).
 43. Weitkunat, K. et al. Importance of propionate for the repression of hepatic lipogenesis and improvement of insulin sensitivity in 
high-fat diet-induced obesity. Mol. Nutr. Food Res. 60, 2611–2621 (2016).
 44. Wong, J. M. W., de Souza, R., Kendall, C. W. C., Emam, A. & Jenkins, D. J. A. Colonic health: fermentation and short chain fatty 
acids. J. Clin. Gastroenterol. 40, 235–43 (2006).
 45. Ohira, H., Tsutsui, W. & Fujioka, Y. Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and 
Atherosclerosis? J. Atheroscler. Thromb. 24, 660–672 (2017).
 46. Demigné, C. et al. Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes. 
Br. J. Nutr. 74, 209–19 (1995).
 47. Gao, Z. et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 1509–17 (2009).
 48. Nordgaard, I., Mortensen, P. B. & Langkilde, A. M. Small intestinal malabsorption and colonic fermentation of resistant starch and 
resistant peptides to short-chain fatty acids. Nutrition 11, 129–37
 49. Zarling, E. J. & Ruchim, M. A. Protein origin of the volatile fatty acids isobutyrate and isovalerate in human stool. J. Lab. Clin. Med. 
109, 566–70 (1987).
 50. Smith, E. & Macfarlane, G. Dissimilatory Amino Acid Metabolism in Human Colonic Bacteria. Anaerobe 3, 327–337 (1997).
 51. Macfarlane, G. T., Allison, C., Gibson, S. A. & Cummings, J. H. Contribution of the microflora to proteolysis in the human large 
intestine. J. Appl. Bacteriol. 64, 37–46 (1988).
 52. Hughes, R., Magee, E. A. & Bingham, S. Protein degradation in the large intestine: relevance to colorectal cancer. Curr. Issues Intest. 
Microbiol. 1, 51–8 (2000).
 53. Heimann, E., Nyman, M., Pålbrink, A.-K., Lindkvist-Petersson, K. & Degerman, E. Branched short-chain fatty acids modulate 
glucose and lipid metabolism in primary adipocytes. Adipocyte 5, 359–368 (2016).
 54. Nagai, F., Morotomi, M., Watanabe, Y., Sakon, H. & Tanaka, R. Alistipes indistinctus sp. nov. and Odoribacter laneus sp. nov., 
common members of the human intestinal microbiota isolated from faeces. Int. J. Syst. Evol. Microbiol. 60, 1296–1302 (2010).
 55. Allison, M. J., Bryant, M. P., Katz, I. & Keeney, M. Metabolic function of branched-chain volatile fatty acids, growth factors for 
ruminococci. II. Biosynthesis of higher branched-chain fatty acids and aldehydes. J. Bacteriol. 83, 1084–93 (1962).
 56. Bernalier, A., Willems, A., Leclerc, M., Rochet, V. & Collins, M. D. Ruminococcus hydrogenotrophicus sp. nov., a new H2/CO2-
utilizing acetogenic bacterium isolated from human feces. Arch. Microbiol. 166, 176–83 (1996).
 57. Mallol, R. et al. Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy. J. Lipid Res. 56, 
737–46 (2015).
 58. Lluch, J. et al. The Characterization of Novel Tissue Microbiota Using an Optimized 16S Metagenomic Sequencing Pipeline. PLoS 
One 10, e0142334 (2015).
 59. Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).
 60. Torii, T. et al. Measurement of short-chain fatty acids in human faeces using high-performance liquid chromatography: specimen 
stability. Ann. Clin. Biochem. 47, 447–52 (2010).
 61. Mosele, J. I. et al. Effect of daily intake of pomegranate juice on fecal microbiota and feces metabolites from healthy volunteers. Mol 
Nutr Food Res. 59, 1942–53 (2015).
www.nature.com/scientificreports/
13Scientific RepoRts |          (2019) 9:1772  | https://doi.org/10.1038/s41598-019-38874-3
Acknowledgements
The research leading to these results has received funding from the People Programme (Marie Curie Actions) of 
the Seventh Framework Programme of the European Union (FP7/2007-2013) under REA grant agreement No. 
600388 (TECNIOspring Progamme) and from the Agency for Business Competitiveness of the Government of 
Catalonia ACCIÓ that support the fellowship given to Ana Belén Granado-Serrano (TECSPR14-0-0023). I.A.L 
enjoys a post-doctoral contract (2017PMF-POST2-19) from the European Union’s Horizon 2020 research and 
innovation programme under the Marie Sklodowska-Curie grant agreement and from the Universitat Rovira i 
Virgili (URV).
Author Contributions
S.J.C.E. and P.-O.M. conceived and designed the project. S.V. and R.S.M. helped to recruit volunteers. B.R. helped 
to collect samples and manage volunteers. S.J.C.E., M.-G.M. and G.-S.A.B. collected samples and performed 
experiments. L.I.A. and R.L. carried out the analysis of bile acids and cholesterol in faeces. S.J.C.E., M.-G.M. and 
G.-S.A.B. analysed and interpreted the data. V.E. helped with statistical analysis. S.J.C.E. and G.-S.A.B. wrote the 
paper. All authors commented on the manuscript.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-019-38874-3.
Competing Interests: The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2019
